GET THE APP

..

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Hanny Ory

Department of Hematology, Medical School, National and Kapodistrian University of Athens, “Laiko” General Hospital, 11527 Athens, Greece

Publications
  • Mini Review   
    Cardiotoxicity in Blood Cancer: Pharmacological Protection and Control
    Author(s): Almeida Michele* and Hanny Ory

    Present day treatment modalities in hematology have worked on clinical results of patients with hematological malignancies. By the by, numerous new or traditional anticancer medications influence the cardiovascular framework, bringing about different heart issues, including left ventricular brokenness, cardiovascular breakdown, blood vessel hypertension, myocardial ischemia, cardiovascular musicality aggravations, and QTc prolongation on electrocardiograms. As these confusions might endanger the essentially better result of present day anticancer treatments, it is vital to get comfortable with all parts of cardiotoxicity and give proper consideration instantly to these patients. Likewise, laid out and new medications add to essential and auxiliary cardiovascular infections avoidance. This audit centers around the clinical signs, preventive procedures, and drug .. Read More»
    DOI: 10.37421/2167-7689.2022.11.317

    Abstract HTML PDF

Google Scholar citation report
Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward